Guidelines from the American Society of Clinical Oncology (ASCO) and the National Comprehensive Cancer Network (NCCN) recommend all women diagnosed with epithelial ovarian cancer undergo germline genetic testing for BRCA1 and BRCA2 and other susceptible genes, regardless of their family history.6,7. This evidence concerns the gene BRCA1 and ovarian carcinoma.